Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alon Ben-David

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Journal of Neurology|July 30, 2020
Parity and disability progression in relapsing-remitting multiple sclerosisAnat Achiron, Alon Ben-David, Michael Gurevich, et al.
Plos One|January 30, 2014
Evaluating the synergistic neutralizing effect of anti-botulinum oligoclonal antibody preparationsEran Diamant, Bat-El Lachmi, Adi Keren, et al.
Journal of Molecular Biology|April 25, 2006
The structure of an inverting GH43 beta-xylosidase from Geobacillus stearothermophilus with its substrate reveals the role of the three catalytic residuesChristian Brüx, Alon Ben-David, Dalia Shallom-Shezifi, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2018
A Novel Rabbit Spirometry Model of Type E Botulism and Its Use for the Evaluation of Postsymptom Antitoxin EfficacyEran Diamant, Avi Pass, Osnat Rosen, et al.
Vaccine|November 28, 2017
An in vitro cell-based potency assay for pharmaceutical type A botulinum antitoxinsAmram Torgeman, Eran Diamant, Lilach Levin, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
A Novel Running Wheel Mouse Model for Botulism and Its Use for the Evaluation of Postsymptom Antitoxin EfficacyArieh Schwartz, Alon Ben David, Mordechai Hotoveli, et al.
Scientific Reports|October 24, 2025
Elucidating the activation mechanism of botulinum neurotoxin a: role of α-clostripain and NTNHShani Pitel, Ada Barnea, Eran Diamant, et al.
Scientific Reports|May 21, 2024
Short- and long-term outcomes of pulmonary exposure to a sublethal dose of ricin in miceAnita Sapoznikov, Yentl Evgy, Amir Ben-Shmuel, et al.
Toxins|May 31, 2017
Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody PreparationsAmram Torgeman, Eyal Ozeri, Alon Ben David, et al.
Biochemistry|January 5, 2005
Biochemical characterization and identification of the catalytic residues of a family 43 beta-D-xylosidase from Geobacillus stearothermophilus T-6Dalia Shallom, Maya Leon, Tsafrir Bravman, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of Neurology|July 30, 2020
Parity and disability progression in relapsing-remitting multiple sclerosisAnat Achiron, Alon Ben-David, Michael Gurevich, et al.
Plos One|January 30, 2014
Evaluating the synergistic neutralizing effect of anti-botulinum oligoclonal antibody preparationsEran Diamant, Bat-El Lachmi, Adi Keren, et al.
Journal of Molecular Biology|April 25, 2006
The structure of an inverting GH43 beta-xylosidase from Geobacillus stearothermophilus with its substrate reveals the role of the three catalytic residuesChristian Brüx, Alon Ben-David, Dalia Shallom-Shezifi, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2018
A Novel Rabbit Spirometry Model of Type E Botulism and Its Use for the Evaluation of Postsymptom Antitoxin EfficacyEran Diamant, Avi Pass, Osnat Rosen, et al.
Vaccine|November 28, 2017
An in vitro cell-based potency assay for pharmaceutical type A botulinum antitoxinsAmram Torgeman, Eran Diamant, Lilach Levin, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
A Novel Running Wheel Mouse Model for Botulism and Its Use for the Evaluation of Postsymptom Antitoxin EfficacyArieh Schwartz, Alon Ben David, Mordechai Hotoveli, et al.
Scientific Reports|October 24, 2025
Elucidating the activation mechanism of botulinum neurotoxin a: role of α-clostripain and NTNHShani Pitel, Ada Barnea, Eran Diamant, et al.
Scientific Reports|May 21, 2024
Short- and long-term outcomes of pulmonary exposure to a sublethal dose of ricin in miceAnita Sapoznikov, Yentl Evgy, Amir Ben-Shmuel, et al.
Toxins|May 31, 2017
Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody PreparationsAmram Torgeman, Eyal Ozeri, Alon Ben David, et al.
Biochemistry|January 5, 2005
Biochemical characterization and identification of the catalytic residues of a family 43 beta-D-xylosidase from Geobacillus stearothermophilus T-6Dalia Shallom, Maya Leon, Tsafrir Bravman, et al.
Pageof 5